Want to join the conversation?
$SKT said it expects the transaction to be modestly accretive to 2016 funds from operations (FFO) per share, excluding acquisition costs, based on in-place financing. The company is currently evaluating various long-term financing alternatives and some financing alternatives, if executed, may be slightly dilutive to 2016 FFO per share.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.